Evidence map›Paper›PMID 26821283›Full record

ArticleGenes and immunity2016

The SLE variant Ala71Thr of BLK severely decreases protein abundance and binding to BANK1 through impairment of the SH3 domain function.

A Díaz-Barreiro, M Bernal-Quirós, I Georg, C Marañón, M E Alarcón-Riquelme, C Castillejo-López

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A Díaz-BarreiroArea of Medical Genomics, Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, PTS, Granada, Spain.
M Bernal-QuirósArea of Medical Genomics, Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, PTS, Granada, Spain.
I GeorgArea of Medical Genomics, Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, PTS, Granada, Spain.
C MarañónArea of Medical Genomics, Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, PTS, Granada, Spain.
M E Alarcón-RiquelmeArea of Medical Genomics, Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, PTS, Granada, Spain.
C Castillejo-LópezDepartment of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala, Sweden.
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESKarolinska Institutet · SEUppsala University · SE

Funding

Molecular Mechanisms and Genetics of AutoimmunityP20GM103456 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2013
$4.8M
NIGMS NIH HHS GM103456-10
6 · The paper itself

Abstract

The B-lymphocyte kinase (BLK) gene is associated genetically with several human autoimmune diseases including systemic lupus erythematosus. We recently described that the genetic risk is given by two haplotypes: one covering several strongly linked single-nucleotide polymorphisms within the promoter of the gene that correlated with low transcript levels, and a second haplotype that includes a rare nonsynonymous variant (Ala71Thr). Here we show that this variant, located within the BLK SH3 domain, is a major determinant of protein levels. In vitro analyses show that the 71Thr isoform is hyperphosphorylated and promotes kinase activation. As a consequence, BLK is ubiquitinated, its proteasomal degradation enhanced and the average life of the protein is reduced by half. Altogether, these findings suggest that an intrinsic autoregulatory mechanism previously unappreciated in BLK is disrupted by the 71Thr substitution. Because the SH3 domain is also involved in protein interactions, we sought for differences between the two isoforms in trafficking and binding to protein partners. We found that binding of the 71Thr variant to the adaptor protein BANK1 is severely reduced. Our study provides new insights on the intrinsic regulation of BLK activation and highlights the dominant role of its SH3 domain in BANK1 binding.

Indexed as

Amino Acid SubstitutionMutationAdaptor Proteins, Signal TransducingAmino Acid SequenceBinding SitesB-LymphocytesCell Line, TumorGene ExpressionHalf-LifeHaplotypesHumansLupus Erythematosus, SystemicMembrane ProteinsModels, MolecularMolecular Sequence DataPromoter Regions, GeneticAdaptor Proteins, Signal TransducingBANK1 protein, humanBLK protein, humanMembrane ProteinsProteasome Endopeptidase ComplexProtein Isoformssrc-Family Kinases

Identifiers

PMID26821283
OpenAlexW2259016923

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.